1. Otellin, V.A., Kucherenko, R.P., Gilerovich, E.G., Usova, I.P., Fedosikhina, L.A., Grigoriev, I.P., and Neokesariiskii, A.A., Morphological reconstructions in brain, caused by a decrease of catecholamine level, Zh. Nevrol. Psychiat., 1984, vol. 84, no. 7, pp. 978–981.
2. Tillet, Y. and Kitahama, K., Distribution of central catecholaminergic neurons: a comparison between ungulates, humans and other species, Histol. Histopathol., 1998, vol. 13, no. 4, pp. 1163–1177.
3. Lorke, D.E., Kwong, W.H., Chan, W.Y., and Yew, D.T., Development of catecholaminergic neurons in the human medulla oblongata, Life Sci., 2003, vol. 73, no. 10, pp. 1315–1331.
4. Pastukhov, Yu.F., Ekimova, I.V., Guzhova, I.V., Romanova, I.V., and Artyukhina, Z.E., Content of chaperone HSP70 in black substance dopaminergic neurons rises in proteasomal dysfunction, Ross. Fiziol. Zh., 2011, vol. 97, no. 7, pp. 649–660.
5. Suckow, S.K., Deichsel, E.L., Ingram, S.L., Morgan, M.M., and Aicher, S.A., Columnar distribution of catecholaminergic neurons in the ventrolateral periaqueductal gray and their relationship to efferent pathways, Synapse, 2013, vol. 67, no. 2, pp. 94–108.